Cargando…
Characterization of a mantle cell lymphoma cell line resistant to the Chk1 inhibitor PF-00477736
Mantle cell lymphoma (MCL) is an aggressive B-cell lymphoma characterized by the chromosomal translocation t(11;14) that leads to constitutive expression of cyclin D1, a master regulator of the G1-S phase. Chk1 inhibitors have been recently shown to be strongly effective as single agents in MCL. To...
Autores principales: | Restelli, Valentina, Chilà, Rosaria, Lupi, Monica, Rinaldi, Andrea, Kwee, Ivo, Bertoni, Francesco, Damia, Giovanna, Carrassa, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741926/ https://www.ncbi.nlm.nih.gov/pubmed/26439697 |
Ejemplares similares
-
Combined inhibition of Chk1 and Wee1 as a new therapeutic strategy for mantle cell lymphoma
por: Chilà, Rosaria, et al.
Publicado: (2014) -
Identification of PLK1 as a New Therapeutic Target in Mucinous Ovarian Carcinoma
por: Affatato, Roberta, et al.
Publicado: (2020) -
BET bromodomain inhibitor birabresib in mantle cell lymphoma: in vivo activity and identification of novel combinations to overcome adaptive resistance
por: Tarantelli, Chiara, et al.
Publicado: (2018) -
U2OS cells lacking Chk1 undergo aberrant mitosis and fail to activate the spindle checkpoint
por: Carrassa, Laura, et al.
Publicado: (2009) -
Stable CDK12 Knock-Out Ovarian Cancer Cells Do Not Show Increased Sensitivity to Cisplatin and PARP Inhibitor Treatment
por: Chilà, Rosaria, et al.
Publicado: (2022)